Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (121-130 of 418) with videos related to

Pageof 42
Sort By:
Frontiers in Oncology|July 14, 2022
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated <i>RAS</i>/<i>BRAF</i> Wild-Type mCRC PatientsStefania Napolitano, Giulia Martini, Davide Ciardiello, et al.
Cancers|September 13, 2025
KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open ChallengesPietro Paolo Vitiello, Anna Amela Valsecchi, Eleonora Duregon, et al.
Journal of the National Cancer Institute|February 10, 2023
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic reviewGiacomo Bregni, Elena Trevisi, Rita Saúde Conde, et al.
Tumori|March 11, 2024
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM surveyAnna Amela Valsecchi, Vittorio Fusco, Massimo Di Maio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysisJordi Remon, Guillermo Villacampa, Francesco Facchinetti, et al.
Cancer Biology & Therapy|July 8, 2011
Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern ItalyMaddalena Barba, Alfredo Mazza, Carla Guerriero, et al.
Oncology Reports|December 5, 2006
Triplet repeat instability correlates with dinucleotide instability in primary breast cancerClaudia Pizzi, Massimo Di Maio, Santa Daniele, et al.
Anticancer Research|November 3, 2004
Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?Antonella De Luca, Michele Grassii, Monica R Maiello, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 16, 2017
Hormonal treatment and quality of life of prostate cancer patients: new evidenceMarcello Tucci, Gianmarco Leone, Consuelo Buttigliero, et al.
Acta Oncologica (Stockholm, Sweden)|January 10, 2017
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxelConsuelo Buttigliero, Chiara Pisano, Marcello Tucci, et al.
Pageof 42

Showing results (121-130 of 418) with videos related to

Sort By:
Pageof 42
Frontiers in Oncology|July 14, 2022
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated <i>RAS</i>/<i>BRAF</i> Wild-Type mCRC PatientsStefania Napolitano, Giulia Martini, Davide Ciardiello, et al.
Cancers|September 13, 2025
KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open ChallengesPietro Paolo Vitiello, Anna Amela Valsecchi, Eleonora Duregon, et al.
Journal of the National Cancer Institute|February 10, 2023
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic reviewGiacomo Bregni, Elena Trevisi, Rita Saúde Conde, et al.
Tumori|March 11, 2024
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM surveyAnna Amela Valsecchi, Vittorio Fusco, Massimo Di Maio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysisJordi Remon, Guillermo Villacampa, Francesco Facchinetti, et al.
Cancer Biology & Therapy|July 8, 2011
Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern ItalyMaddalena Barba, Alfredo Mazza, Carla Guerriero, et al.
Oncology Reports|December 5, 2006
Triplet repeat instability correlates with dinucleotide instability in primary breast cancerClaudia Pizzi, Massimo Di Maio, Santa Daniele, et al.
Anticancer Research|November 3, 2004
Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?Antonella De Luca, Michele Grassii, Monica R Maiello, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 16, 2017
Hormonal treatment and quality of life of prostate cancer patients: new evidenceMarcello Tucci, Gianmarco Leone, Consuelo Buttigliero, et al.
Acta Oncologica (Stockholm, Sweden)|January 10, 2017
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxelConsuelo Buttigliero, Chiara Pisano, Marcello Tucci, et al.
Pageof 42